Companies: 10,795·Total market cap: $144.5T
Assembly Biosciences, Inc.

Assembly Biosciences, Inc.

ASMBNASDAQHealthcare● Active
$22.56
$-0.35(-1.51%)
Market Cap$358464382
P/E Ratio
52W High$39.71
52W Low$15.54
Overview

Assembly Biosciences, Inc. (ASMB) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ASMB · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.58asmb eps ttm · asmb earnings per shareEarnings history
PE Ratio (TTM)asmb pe ratio ttm · asmb price to earningsPE Ratio deep dive
Revenue (TTM)$71.1Masmb revenue ttm · asmb annual revenueFull revenue history
Dividend YieldNo Dividenddoes asmb pay dividends · asmb dividend yieldDividend history
Shares Outstanding11.2Masmb shares outstanding · asmb floatShares outstanding history
Next EarningsAug 5, 2026Est.asmb earnings date · asmb next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$72.3M▲ +153.52% YoY
202320242025
assembly biosciences, inc. revenue · asmb revenue 2025
FY 2025Net Income-$6.1M▲ +84.76% YoY
202320242025
assembly biosciences, inc. net income · asmb profit 2025
FY 2025EPS$-0.55▲ +91.78% YoY
202320242025
asmb eps · assembly biosciences, inc. earnings per share 2025
TTM:Revenue: $71.1MNet Income: -$6.4MEPS: $-0.58View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis asmb a buy · asmb analyst rating
Strong Buy
0
Buy
6
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$22.55Current
$37.67Avg Target67.01% upside
$40.00High
asmb price target · asmb 12 month forecast

Total: 11 · Buy rate: 54.5%

The ASMB analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $37.67, representing +67.01% upside from the current price of $22.55.

Stock Performance

Full History
1D-1.51%
1W-8.31%
1M-24.16%
3M-20.22%
YTD-33.68%
1Y+40.35%
5Y-54.16%

About Assembly Biosciences, Inc.

CEOJason A. Okazaki
IPO DateDec 17, 2010
Employees73
CountryUS

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections wit…

what is assembly biosciences, inc. · asmb stock overview · assembly biosciences, inc. company profile · who is assembly biosciences, inc. ceo · asmb NASDAQ · assembly biosciences, inc. headquarters · assembly biosciences, inc. business segments

About Stock Overview & Key Data

Assembly Biosciences, Inc. (ASMB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 17, 2010. As of the latest trading session, ASMB stock price is $22.55, with a market capitalization of $358.5M. The stock has returned +40.35% over the past 12 months and -33.68% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Assembly Biosciences, Inc. stock is Buy, with an average 12-month price target of $37.67. In fiscal year 2025, Assembly Biosciences, Inc. reported revenue of $72.3M and net income of -$6.1M. For detailed data — including Assembly Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Assembly Biosciences, Inc. (ASMB) stock price is $22.55. The stock is traded on NASDAQ under the ticker symbol ASMB. The 52-week range is $15.54 – $39.71.

ASMB stock priceASMB quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice